Matriptase-2 is essential for hepcidin repression during fetal life and postnatal development in mice to maintain iron homeostasis

Blood

Volumn 124, Issue 3, 2014, Pages 441-444

  Willemetz, Alexandra ^a,b,c,d   Lenoir, Anne ^a,b,c,d   Deschemin, Jean Christophe ^a,b,c,d   Lopez Otin, Carlos ^e   Ramsay, Andrew J ^e   Vaulont, Sophie ^a,b,c,d   Nicolas, Gaël ^a,b,c,d  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d UNIVERSITY OF OVIEDO   (Spain)

^e DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPCIDIN; IRON; MATRIPTASE; MATRIPTASE 2; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROPOIESIS; FEMALE; GENE REPRESSION; GROWTH INHIBITION; HOMEOSTASIS; IRON ABSORPTION; IRON DEFICIENCY ANEMIA; IRON METABOLISM; MALE; MICROCYTIC ANEMIA; MILK; MOLECULAR MECHANICS; MOUSE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL GROWTH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN IMMOBILIZATION;

ANEMIA, IRON-DEFICIENCY; ANIMALS; BONE MORPHOGENETIC PROTEIN 6; DOWN-REGULATION; FEMALE; FETUS; HEPCIDINS; HOMEOSTASIS; HUMANS; IRON; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PREGNANCY; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 84904464902     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-01-551150     Document Type: Article

References (17)

1. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823(9):1434-1443.
2. Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency. Science. 2008;320(5879):1088-1092. (Pubitemid 351929552)
3. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab. 2008;8(6):502-511.
4. Finberg KE, Heeney MM, Campagna DR, et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet. 2008;40(5):569-571. (Pubitemid 351601217)
5. Camaschella C. Iron and hepcidin: a story of recycling and balance. Hematology Am Soc Hematol Educ Prog. 2013;2013:1-8.
6. Truksa J, Gelbart T, Peng H, Beutler E, Beutler B, Lee P. Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6. Br J Haematol. 2009;147(4):571-581.
7. Finberg KE, Whittlesey RL, Fleming MD, Andrews NC. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood. 2010;115(18):3817-3826.
8. Lenoir A, Deschemin JC, Kautz L, et al. Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6. Blood. 2011;117(2):647-650.
9. Nicolas G, Bennoun M, Porteu A, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA. 2002;99(7):4596-4601. (Pubitemid 34286030)
10. Courselaud B, Pigeon C, Inoue Y, et al. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem. 2002;277(43):41163-41170. (Pubitemid 35215708)
11. Folgueras AR, de Lara FM, Pendás AM, et al. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood. 2008;112(6):2539-2545.
12. Deschemin JC, Vaulont S. Role of hepcidin in the setting of hypoferremia during acute inflammation. PLoS ONE. 2013;8(4):e61050.
13. Torrance JD, Bothwell TH. Tissue iron stores. Methods Hematol. 1980;1:90-115.
14. Donovan A, Lima CA, Pinkus JL, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005;1(3):191-200. (Pubitemid 43960600)
15. Krijt J, Fujikura Y, Ramsay AJ, Velasco G, Nečas E. Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6). Blood Cells Mol Dis. 2011;47(2):133-137.
16. Kautz L, Jung G, Valore E, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism [published online ahead of print June 1, 2014]. Nat Genet. doi:10.1038/ng.2996.
17. Nicolas G, Deschemin JC, Ramsay AJ, et al. Is EPO therapy able to correct iron deficiency anaemia caused by matriptase-2 deficiency? Br J Haematol. 2011;152(4):498-500.